Frederik R. Teunissen

Utrecht University

Papers

1

Total Citations

21

H-Index

1

About

Frederik R. Teunissen is a pioneering clinical researcher in urological oncology, whose work centers on patient-reported outcomes and innovative trial designs for prostate cancer. His major contribution is the development and implementation of the Utrecht Prostate Cohort (UPC), the first "trials within cohorts" (TwiCs) platform specifically for prostate cancer. This groundbreaking methodology allows for the efficient evaluation of interventions by embedding randomized trials within an ongoing observational cohort, significantly reducing costs and improving recruitment. His most cited work, detailing the first patient-reported outcomes from this platform (2022, 21 citations), demonstrates how this approach can capture real-world patient experiences and streamline comparative effectiveness research. By integrating patient perspectives directly into trial infrastructure, Teunissen is reshaping how prostate cancer studies are conducted, making them more pragmatic and patient-centered. His work represents a significant step forward in evidence-based urologic care, offering a scalable model for future oncology research.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer
21 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Utrecht University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago